The pop analysis of why conservative Blue Dog Democrats have slowed the health care overhaul to win concessions is that they are tools of the insurers and drug company executives who donate to their campaigns.
Nobel Prize-winning New York Times op-ed writer Paul Krugman fumed this week about the Blue Dogs, raising the possibility that they are "nothing but corporate tools, defending special interests" and noting their campaign receipts before softening his stance to say he's "not quite that cynical."
Krugman, who doesn't cover Congress, and others of his ilk should look at an electoral map in addition to campaign finance reports.
In 2008, President Obama lost six of the seven districts of the Blue Dogs who temporarily put the brakes on the bill in the Energy and Commerce Committee. And, it's safe to say Obama is more popular in those districts than the House leaders who wrote the health bill.

